Curaderm BEC5
Intralesion and CuradermBEC5
Topical Combination Therapies of
Solasodine Rhamnosyl Glycosides
Derived from the Eggplant or Devil’s Apple
Result in Rapid Removal of Large Skin Cancers.
Methods of Treatment Compared
Solasodine rhamnosyl glycosides (SRGs) are chemotherapeutic agents for the treatment of cancer.
SRGs in a cream formulation, CuradermBEC5, is very effective for the treatment of non-melanoma skin cancers with excellent cosmetic end results.
Intralesion injection of SRGs successfully dispose of very large tumors in animals without any clinical adverse effects.
Basal Cell Carcinoma
The mode of action of SRGs is by apoptosis.
In this study, it is shown that small to large basal cell carcinomas are effectively treated only with topical application of CuradermBEC5.
Here it is reported for the first time that combination of intralesion SRG injection and topical application with CuradermBEC5 in humans reduces the treatment time period by more than half when compared with topical application as the sole treatment regime.
Two intralesion injections of very low doses of SRGs rapidly and effectively remove a large melanoma on a horse.
If rapid removal of large troublesome skin cancers is required then this can be achieved by intralesion and topical treatments.
Intralesion or combination therapy with SRGs may have some applications for melanomas in situ such as lentigo maligna.
 |
Curaderm BEC5
Curaderm BEC5 Eggplant Skin Cancer Cream, an affordable cream, appears to cure and eliminate non-melanoma skin cancers in weeks. |
CLICK HERE FOR CURADERM BEC5
